Application Note: Accelerating 3D Microtissue Production
14 September 2015

Preclinical drug development relies on advanced in vitro models with a high degree of standardization to achieve maximal predictivity for an efficient compound de-risking strategy. InSphero's scaffold-free organo-typic three-dimensional (3D) microtissue spheroids fulfil these requirements as they can be produced and assayed by standard automated liquid handling systems. The Integra Viaflo 96 Channel Electronic Hand-Held Pipette is perfectly suited to produce 3D microtissues in InSphero's GravityPLUSTM hanging drop plate and to further culture and process them in the GravityTRAPTM platform, as described in this application note. 

Company